Tigecycline for treatment of nosocomial-acquired pneumonia possibly caused by multi-drug resistant strains of Stenotrophomonas maltophilia

Journal of Chemotherapy

Volumn 20, Issue 6, 2008, Pages 761-763

  Blanquer Escribano, David ^a   De Otero, J ^a   Padilla, E ^a   Gomez F ^a   Mayol, A ^a   Irigaray, R ^a   Espejo, P ^a   Rada, M A ^a   Makrantoni, G ^a   Perez A R ^a  

^a HOSPITAL DE MANACOR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CARBAPENEM; CASPOFUNGIN; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; DIURETIC AGENT; IMIPENEM; LINEZOLID; OXYGEN; TIGECYCLINE; TOBRAMYCIN; VORICONAZOLE;

ACHROMOBACTER XYLOSOXIDANS; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS NIGER; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENTEROBACTER CLOACAE; FOLLOW UP; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LEUKOCYTOSIS; LOADING DRUG DOSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; OXYGEN SATURATION; PHYSICAL EXAMINATION; PNEUMONIA; PRESCRIPTION; RESPIRATORY FAILURE; STENOTROPHOMONAS MALTOPHILIA;

EID: 59349114909     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.6.761     Document Type: Article

References (13)

1. Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis 2006; 43: 518-24.
2. Noskin GA. Tigecycline: a new glycylcycline for treatment of serious infections. Clin Infect Dis 2005; 41 (Suppl 5): S303-14.
3. Saner FH, Heder M, Rath P, Gensicke J, Radtke A, Drühe N, et al. Successful salvage therapy with tigecycline after linezolid failure in a liver transplant recipient with MRSA pneumonia. Liver Transp. 2006; 12: 1689-92.
4. Muh̃oz-Price LS, Lolans K, Quinn JP. Four cases of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections treated with tigecycline. Scand J Infect Dis 2006; 38: 1081-4.
5. PMaclayton DO, Hall RG 2. Pharmacological treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Ann Pharmacother 2007; 41(2): 235-44. Epub 2007 Mar 7. Review. PMID: 17346938 [PubMed - indexed for MEDLINE].
6. Daly MW, Riddle DJ, Ledeboer NA, Dunne WM, Ritchie DJ. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacother 2007; 27(7): 1052-7.
7. Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM. Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy 2007; 27(8): 1198-1201.
8. Curdo D, Fernández F, Duret F. Initial use of tigecycline in Argentina (article in Spanish). Rev Chilena Infectol 2007; 24(6): 497-499.
9. Maroko R, Cooper A, Dukart G, Dartois N Gandjini H. Results of Phase 3 study comparing a tigecycline (TGC) regimen with an imipenem/cilastatin (IMI) regimen in treatment of patients (Pts) with hospital-acquired pneumonia (HAP). L-730 Wyeth Pharmaceuticals.
10. Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Diagn Microbiol Infect Dis 2005; 52: 187-93.
11. Mundalidharan G, Micalizzi M, Speth J, Raible D, Troy S. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob Agents and Chemother 2005; 49: 220-9.
12. Mensa J, Soriano A, Martínez JA. Initial empiric antimicrobial therapy for suspected severe infections caused by multidrug resistant pathogens. Enferm Infecc Microbiol Clin, Monogr 2006; 5: 44-52.
13. Betriu C, Rodríguez-Avial I, Sánchez BA, Gómez M, Picazo JJ. Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia. J Antimicrob Chemother 2002; 50: 758-9.